Market
Baxter’s shares fall as Q3 probability dips despite revenue growth
Baxter International's stock declined more than 4% on October 29 following third-quarter results showing adjusted EPS down 16% year-over-year, despite revenue growth. The earnings miss offset positive top-line performance, reflecting margin pressures or increased costs affecting profitability.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network